These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33895552)

  • 1. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
    Yu HM; Chung HK; Park KS
    Biochem Biophys Res Commun; 2021 Jun; 558():57-63. PubMed ID: 33895552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDE 5 inhibitor improves insulin sensitivity by enhancing mitochondrial function in adipocytes.
    Yu HM; Chung HK; Kim KS; Lee JM; Hong JH; Park KS
    Biochem Biophys Res Commun; 2017 Nov; 493(1):631-636. PubMed ID: 28888986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
    Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
    Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
    Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
    Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice.
    Wang B; Zhu X; Yu S; Xue H; Deng L; Zhang Y; Zhang Y; Liu Y
    Biochem Biophys Res Commun; 2024 Aug; 722():150170. PubMed ID: 38797152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.
    Bellanti F; Villani R; Tamborra R; Blonda M; Iannelli G; di Bello G; Facciorusso A; Poli G; Iuliano L; Avolio C; Vendemiale G; Serviddio G
    Redox Biol; 2018 May; 15():86-96. PubMed ID: 29220698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance is mechanistically linked to hepatic mitochondrial remodeling in non-alcoholic fatty liver disease.
    Shannon CE; Ragavan M; Palavicini JP; Fourcaudot M; Bakewell TM; Valdez IA; Ayala I; Jin ES; Madesh M; Han X; Merritt ME; Norton L
    Mol Metab; 2021 Mar; 45():101154. PubMed ID: 33359401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 72 regulates hepatic lipid accumulation.
    Archer AE; Rogers RS; Von Schulze AT; Wheatley JL; Morris EM; McCoin CS; Thyfault JP; Geiger PC
    Am J Physiol Regul Integr Comp Physiol; 2018 Oct; 315(4):R696-R707. PubMed ID: 29924632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
    Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
    Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
    Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
    World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with didemnin B, an elongation factor 1A inhibitor, improves hepatic lipotoxicity in obese mice.
    Hetherington AM; Sawyez CG; Sutherland BG; Robson DL; Arya R; Kelly K; Jacobs RL; Borradaile NM
    Physiol Rep; 2016 Sep; 4(17):. PubMed ID: 27613825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
    J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of exenatide on mitochondrial lipid metabolism in mice with nonalcoholic steatohepatitis.
    Kalavalapalli S; Bril F; Guingab J; Vergara A; Garrett TJ; Sunny NE; Cusi K
    J Endocrinol; 2019 Jun; 241(3):293-305. PubMed ID: 31082799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
    Akie TE; Liu L; Nam M; Lei S; Cooper MP
    PLoS One; 2015; 10(5):e0125617. PubMed ID: 25933096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPP-4 Inhibition with Anagliptin Reduces Lipotoxicity-Induced Insulin Resistance and Steatohepatitis in Male Mice.
    Sakai Y; Chen G; Ni Y; Zhuge F; Xu L; Nagata N; Kaneko S; Ota T; Nagashimada M
    Endocrinology; 2020 Oct; 161(10):. PubMed ID: 32790863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOC3 Protein Is Not a Predisposing Factor for Fat-induced Nonalcoholic Fatty Liver Disease in Mice.
    Cheng X; Yamauchi J; Lee S; Zhang T; Gong Z; Muzumdar R; Qu S; Dong HH
    J Biol Chem; 2017 Mar; 292(9):3692-3705. PubMed ID: 28115523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease.
    Stacchiotti A; Favero G; Lavazza A; Golic I; Aleksic M; Korac A; Rodella LF; Rezzani R
    PLoS One; 2016; 11(1):e0148115. PubMed ID: 26824477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice.
    Lu H; Yuan X; Zhang Y; Han M; Liu S; Han K; Liang P; Cheng J
    Biomed Pharmacother; 2020 Sep; 129():110347. PubMed ID: 32535386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.